[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Pages 57493-57494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23316]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2016-0122]
Program-Specific Guidance About Medical Use Licenses
AGENCY: Nuclear Regulatory Commission.
ACTION: NUREG; issuance.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has issued
Revision 3 to NUREG-1556, Volume 9, ``Consolidated Guidance About
Materials Licenses: Program-Specific Guidance About Medical Use
Licenses.'' NUREG-1556 Volume 9 has been revised to include information
on updated regulatory requirements, safety culture, security of
radioactive materials, protection of sensitive information, and changes
in regulatory policies and practices consistent with current
regulations. This volume is intended for use by applicants, licensees,
and the NRC staff.
DATES: NUREG 1556, Volume 9, Revision 3, was published in September
2019.
ADDRESSES: Please refer to Docket ID NRC 2016-0122 (NUREG-1556, Vol. 9,
Rev. 3), when contacting the NRC about the availability of information
regarding this document. You may obtain publicly-available information
related to this document using any of the following methods:
Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC-2016-0122. Address
questions about NRC dockets to Jennifer Borges; telephone: 301-287-
9127; email: [email protected]. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to [email protected].
NUREG-1556, Volumes 9, Revision 3, is located at ADAMS Accession No.
ML19256C219. This document is also available on the NRC's public
website at http://www.nrc.gov/reading-rm/doc-collections/nuregs/staff/sr1556/ under ``Consolidated Guidance About Materials Licenses (NUREG-
1556).''
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Dr. Katherine Tapp, Office of Nuclear
Material Safety and Safeguards; U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001; telephone: 301-415-0236; email:
[email protected].
SUPPLEMENTARY INFORMATION:
I. Discussion
The NRC issued a revision to NUREG-1556, Volumes 9, to provide
guidance to existing materials licensees covered under medical use
licenses and to applicants preparing an application for a medical use
license of byproduct material. This NUREG volume also provides the NRC
staff with criteria for evaluating medical use license applications.
The purpose of this notice is to notify the public that the NUREG-1556
volume listed in this document was issued as a final report.
II. Additional Information
The NRC published a notice of the availability of the draft report
for comment version of NUREG-1556, Volume 9, Revision 3 in the Federal
Register on December 6, 2016 (81 FR 87978), with an original public
comment period of 63 days. The public comment period was extended for
an additional 53 days on January 26, 2017 (82 FR 8545). The public
comment period closed on March 31, 2017. Public comments and the NRC
staff responses to the public comments for NUREG-1556, Volume 9,
Revision 3 are available under ADAMS Accession No. ML18327A102.
III. Congressional Review Act
This NUREG volume is a rule as defined in the Congressional Review
[[Page 57494]]
Act (5 U.S.C. 801-808). However, the Office of Management and Budget
has not found this NUREG revision to be a major rule as defined in the
Congressional Review Act.
Dated at Rockville, Maryland, this 21st day of October 2019.
For the Nuclear Regulatory Commission.
Michael C. Layton,
Director, Division of Materials Safety, Security, State and Tribal
Programs, Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2019-23316 Filed 10-24-19; 8:45 am]
BILLING CODE 7590-01-P